Keyphrases
Glycoprotein VI
100%
Thrombotic Complications
100%
Venous System
100%
Platelet Membrane Glycoprotein VI
100%
Platelets
33%
Leukocytes
33%
Thrombosis
33%
Venous Thromboembolism
33%
Pulmonary Embolism
33%
Thrombus Formation
33%
Venous Thrombus
33%
Thromboinflammation
33%
Megakaryocytes
16%
Venous Thrombosis
16%
Risk Factors
16%
Human Platelets
16%
Fibronectin
16%
Fibrinogen
16%
Collagen
16%
Common Variants
16%
Associated Complications
16%
Ligand Interaction
16%
Thrombus
16%
Mouse Model
16%
Complex Formation
16%
Fibrin
16%
Cancer Metastasis
16%
Laminin
16%
Immunoglobulin Receptor
16%
Arterial Thrombus
16%
Galectin-3 (Gal-3)
16%
Bleeding Phenotype
16%
Pulmonary Cancer
16%
Immunology and Microbiology
Glycoprotein
100%
Venous Circulation
100%
Platelet Glycoprotein
100%
Platelet
33%
Leukocyte
33%
Blood Clotting
33%
Blood Plasma
16%
Intravenous Immunoglobulin
16%
Fibronectin
16%
Mouse Model
16%
Fibrinogen
16%
Preclinical Study
16%
Complex Formation
16%
Megakaryocyte
16%
Laminin
16%
Galectin 3
16%
Medicine and Dentistry
Glycoprotein VI
100%
Venous Circulation
100%
Platelet
22%
Leukocyte
22%
Blood Clotting
22%
Venous Thromboembolism
22%
Pulmonary Embolism
22%
Receptor
11%
Megakaryocyte
11%
Phlebothrombosis
11%
Biological Marker
11%
Metastatic Carcinoma
11%
Thrombosis
11%
Bleeding
11%
Fibrinogen
11%
Lung Cancer
11%
Fibronectin
11%
Thrombus
11%
Complex Formation
11%
Immunoglobulin Receptor
11%
Laminin
11%
Galectin 3
11%
Experimental Thrombosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glycoprotein VI
100%
Thrombus
33%
Venous Thromboembolism
22%
Lung Embolism
22%
Lung Cancer
11%
Receptor
11%
Preclinical Study
11%
Biological Marker
11%
Bleeding
11%
Fibrinogen
11%
Thrombosis
11%
Metastasis
11%
Mouse Model
11%
Fibronectin
11%
Vein Thrombosis
11%
Immunoglobulin Receptor
11%
Laminin
11%
Galectin 3
11%
Experimental Thrombosis
11%